July 2025 Updates from the Lab
Announcing our patient grant fund to accelerate access to promising treatments, alongside with an Open-Source Treatment Registry, enabling rapid, compliant sharing of patient-driven insights.
Accelerating the cure for Long COVID
Over 100 million people worldwide suffer from Long COVID, without approved treatments or diagnostics. Patients can’t afford to wait.
Treatment Leaderboard
#
Treatment
Stage
Category
Community Rating
1
Pemgarda and Paxlovid
Trial design
Monoclonal antibody, viral replication inhibitor
9
2
Pemgarda and Ensitrelvir
Discovery
Monoclonal antibody, viral replication inhibitor
8
3
Ensitrelvir
Pre-clinical
Long-course antiviral
6
4
Pemgarda
Pre-clinical
Monoclonal antibody
6
5
Metformin
Pre-clinical
Long-course antiviral
5
6
PEG Interferon Lambda
Pre-clinical
Immune modulator
5
7
IVIG
Pre-clinical
Monoclonal antibody
5
8
Evusheld and Paxlovid
Case Study
Monoclonal antibody, viral replication inhibitor
5
9
Paxlovid
Pilot
Long-course antiviral
4
10
Remdesivir
Study design
Long-course antiviral
3
11
Molnupiravir
Pre-clinical
Long-course antiviral
2
Pemgarda and Paxlovid
Trial design
Monoclonal antibody, viral replication inhibitor
Rank
1
Community Rating
9
Pemgarda and Ensitrelvir
Discovery
Monoclonal antibody, viral replication inhibitor
Rank
2
Community Rating
8
Ensitrelvir
Pre-clinical
Long-course antiviral
Rank
3
Community Rating
6
Pemgarda
Pre-clinical
Monoclonal antibody
Rank
4
Community Rating
6
Metformin
Pre-clinical
Long-course antiviral
Rank
5
Community Rating
5
PEG Interferon Lambda
Pre-clinical
Immune modulator
Rank
6
Community Rating
5
IVIG
Pre-clinical
Monoclonal antibody
Rank
7
Community Rating
5
Evusheld and Paxlovid
Case Study
Monoclonal antibody, viral replication inhibitor
Rank
8
Community Rating
5
Paxlovid
Pilot
Long-course antiviral
Rank
9
Community Rating
4
Remdesivir
Study design
Long-course antiviral
Rank
10
Community Rating
3
Molnupiravir
Pre-clinical
Long-course antiviral
Rank
11
Community Rating
2
Have your say
Have a hunch one of these might work, or (even better) tried it yourself? Vote here and add your voice to the conversation.
Unlocking Real-World Evidence
Centralized data from individual patient and clinician experiences, creating the infrastructure layer that publicly amplifies the private experiments already happening.
Surfacing Signal from Noise
Patient data and experimentation are structured to rapidly reveal which treatments deliver outcomes—and for whom—turning fragmented insights into clear, actionable discoveries.
Accelerating Discoveries into Scalable Treatments
We reward patients for high-quality contributions — from validated symptom surveys to biomarker data — through milestone prizes and direct compensation. This approach ensures robust, actionable data and speeds the path to scalable treatments beyond what traditional systems can achieve.
Transparent and Decentralized
Powered by decentralized science, patients and researchers hold governance tokens granting them a voice in research priorities and ethical IP use.
Are you working on a breakthrough treatment for Long COVID?
There are a few theories about what causes Long COVID. We’re focused on one - viral persistence, or virus that sticks around after the initial infection. If you have ideas for antiviral or immune modulatory approaches to clearing persistent virus, submit them here and we may fund them.
Join the mission to accelerate a cure.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus ut venenatis enim. Suspendisse eu leo ipsum. Phasellus faucibus lorem sed mi varius pellentesque. Mauris vel elit tincidunt, pharetra arcu venenatis, mattis nisi.
